UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 07,
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more XTL Biopharmaceuticals Charts.
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more XTL Biopharmaceuticals Charts.

News Xtl Biopharmaceuticals Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 22 Juli 2024 (11 Stunden vor) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 12 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 5 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)
XTL Entered Definitive Agreement to Acquire The Social Proxy
Mittwoch 5 Juni 2024 (2 Monate vor) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 13 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)
XTL To Aquire The Social Proxy
Mittwoch 20 März 2024 (4 Monate vor) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 15 November 2023 (8 Monate vor) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 20 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Freitag 20 Oktober 2023 (9 Monate vor) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 10 August 2023 (11 Monate vor) • Edgar (US Regulatory)

Weitere Xtl Biopharmaceuticals Ltd News-Artikel